Kalaris Therapeutics, Inc. (KLRS) — Strategic Asset Allocation Index
Kalaris Therapeutics, Inc. (KLRS) has a Strategic Asset Allocation Index of 11.2% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $7.65 Million) total $7.65 Million, measured against net assets of $68.56 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Kalaris Therapeutics, Inc. net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Kalaris Therapeutics, Inc. (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Kalaris Therapeutics, Inc. from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Kalaris Therapeutics, Inc. (KLRS) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|